Nesmotrya na uspekhi v ponimanii patogeneza i vozmozhnosti sovremennoy farmakoterapii otmechaetsya postoyannyy i neuklonnyy rost chislennosti bol"nykh bronkhial"noy astmoy (BA). V nastoyashchee vremya BA nezavisimo ot stepeni tyazhesti schitaetsya khronicheskim vospalitel"nym zabolevaniem dykhatel"nykh putey, etiologicheskiy faktor kotorogo neizvesten. Dannyy tip vospaleniya tesno vzaimosvyazan s bronkhial"noy giperreaktivnost"yu, khotya mekhanizm etoy vzaimosvyazi na nastoyashchiy moment polnost"yu ne raskryt. Vozmozhnosti sovremennoy farmakoterapii kontroliruemoy s pomoshch"yu glyukokortikosteroidov (GKS) pozvolyayut dobit"sya v bol"shinstve sluchaev stoykoy remissii. Odnako, stupenchatyy podkhod k naznacheniyu ingalyatsionnykh GKS ( GINA, 2007) trebuet primeneniya v ryade sluchaev dostatochno vysokikh doz preparatov. V to zhe vremya ispol"zovanie ingalyatsionnykh GKS podavlyaet mestnyy immunitet, sposobstvuet razvitiyu steroidnoy zavisimosti i drugikh nezhelatel"nykh yavleniy. V svyazi s etim ves"ma aktual"nym yavlyaetsya vopros izucheniya osobennostey kliniko-laboratornoy diagnostiki i vozmozhnostey ispol"zovaniya sistemnykh antimikotikov v lechenii bol"nykh s bronkhial"noy astmoy.